Ever wonder how the latest Chronic Spontaneous Urticaria (CSU) treatments are changing patient care? In this episode, Kortney and Dr. Gupta talk with Dr. Matthew Zirwas about when to start biologic therapies like Xolair (omalizumab). They also discuss the new medications for treating chronic hives, such as Dupixent, Remibrutinib, and Barzolvolimab, and how these drugs target the mast cell.

Did you miss the previous episodes in the series? Check out:
1️⃣    • Understanding Chronic Spontaneous Urt...  
2️⃣    • Diagnosing Chronic Spontaneous Urticaria  
3️⃣    • Chronic Spontaneous Urticaria Treatments  
4️⃣    • Living with Chronic Spontaneous Urtic...  
5️⃣    • Common Myths and Misunderstandings ab...  

We thank Novartis for sponsoring this episode.

Allergy, Asthma & Immunology Innovations Podcast
Allergy & Asthma Network partners with The Itch Podcast to produce podcast episodes and series
covering a wide range of subjects related to asthma, allergies, immunology and eczema. Join Payel Gupta, MD and Kortney as they dive into the complexities of medical diagnosis, offering balanced episodes with both medical and patient perspectives to help you live a healthier life.

More from the Allergy & Asthma Network:

More Allergy, Asthma & Immunology Innovations Podcast episodes:
https://allergyasthmanetwork.org/podc...

Latest news articles:
https://allergyasthmanetwork.org/news/

Asthma content:
https://allergyasthmanetwork.org/what...

Allergy content:
https://allergyasthmanetwork.org/alle...

Eczema content:
https://allergyasthmanetwork.org/what...

Anaphylaxis content:
https://allergyasthmanetwork.org/anap...

Related conditions:
https://allergyasthmanetwork.org/heal...